Article
Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients.
Pharmacogenetics and genomics - 1 Feb 2006
Uesugi Miwa, Masuda Satohiro, Katsura Toshiya, Oike Fumitaka, Takada Yasutsugu, Inui Ken-ichi
Abstract excerpt
It has been reported that hepatic and intestinal cytochrome P450 (CYP) 3A4, CYP3A5 and P-glycoprotein affect the pharmacokinetics of tacrolimus, and that these proteins are associated with the large inter-individual variation in the pharmacokinetics of this drug. We previously showed that the concentration/dose ratio of tacrolimus tended to be lower in recipients of living-donor liver transplantation (LDLT) with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
